Signaling networks in gastric cancer cells revealed by phosphoproteomics

Journal of Proteomics and Bioinformatics

Volumn 3, Issue 4, 2010, Pages 113-120

  Yan, Guang Rong ^a   Chen, Nan Peng ^a   Huang, Ya Dong ^a   Ding, Wen ^a   He, Gui Wei ^a   Xiao, Chuan Le ^a   Yin, Xing Feng ^a   He, Qing Yu ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

Drug targets; Gastric cancer; Phosphorylation; Proteomics; Signaling networks

Indexed keywords

EID: 77951735882     PISSN: None     EISSN: 0974276X     Source Type: Journal    
DOI: 10.4172/jpb.1000129     Document Type: Article

References (33)

1. Arslan MA, Kutuk O, Basaga H (2006) Protein kinases as drug targets in cancer. Curr Cancer Drug Targets 6: 623-634.
2. Beausoleil SA, Jedrychowski M, Schwartz D, Elias JE, Villen J, et al. (2004) Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc Natl Acad Sci USA 101: 12130-12135.
3. Blume-Jensen P, Hunter T (2001) Oncogenic kinase signalling. Nature 411: 355-365.
4. Brill LM, Salomon AR, Ficarro SB, Mukherji M, Stettler-Gill M, et al. (2004) Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Anal Chem 76: 2763-2772.
5. Cans C, Mangano R, Barila D, Neubauer G, Superti-Furga G (2000) Nuclear tyrosine phosphorylation: the beginning of a map. Biochem Pharmacol 60: 1203-1215.
6. Ding SZ, Olekhnovich IN, Cover TL, Peek RM Jr, Smith MF Jr, et al. (2008) Helicobacter pylori and mitogen-activated protein kinases mediate activator protein-1 (AP-1) subcomponent protein expression and DNA-binding activity in gastric epithelial cells. FEMS Immunol Med Microbiol 53: 385-394.
7. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, et al. (1996) Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2: 561-566.
8. Ficarro SB, McCleland ML, Stukenberg PT, Burke DJ, Ross MM, et al. (2002) Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol 20: 301-305.
9. Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, et al. (2006) Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 355: 2733-2743.
10. Hunter T (2000) Signaling--2000 and beyond. Cell 100: 113-127.
11. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, et al. (2009) STRING 8--a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 37: D412-416.
12. Kim JE, Tannenbaum SR, White FM (2005) Global phosphoproteome of HT-29 human colon adenocarcinoma cells. J Proteome Res 4: 1339-1346.
13. Larsen MR, Thingholm TE, Jensen ON, Roepstorff P, Jorgensen TJ (2005) Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol Cell Proteomics 4: 873-886.
14. Li X, Huang Y, Jiang J, Frank SJ (2008) ERK-dependent threonine phosphorylation of EGF receptor modulates receptor downregulation and signaling. Cell Signal 20: 2145-2155.
15. Macek B, Mijakovic I, Olsen JV, Gnad F, Kumar C, et al. (2007) The serine/ threonine/tyrosine phosphoproteome of the model bacterium Bacillus subtilis. Mol Cell Proteomics 6: 697-707.
16. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S (2002) The protein kinase complement of the human genome. Science 298: 1912-1934.
17. Meloche S, Pouyssegur J (2007) The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 26: 3227-3239.
18. Nichols AM, White FM (2009) Manual validation of peptide sequence and sites of tyrosine phosphorylation from MS/MS spectra. Methods Mol Biol 492: 143-160.
19. Obenauer JC, Cantley LC, Yaffe MB (2003) Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Nucleic Acids Res 31: 3635-3641.
20. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, et al. (2006) Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 127: 635-648.
21. Pan C, Gnad F, Olsen JV, Mann M (2008) Quantitative phosphoproteome analysis of a mouse liver cell line reveals specificity of phosphatase inhibitors. Proteomics 8: 4534-4546.
22. Patel D, Bassi R, Hooper A, Prewett M, Hicklin DJ, et al. (2009) Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER- 2 heterodimerization and activation. Int J Oncol 34: 25-32.
23. Rikova K, Guo A, Zeng Q, Possemato A, Yu J, et al. (2007) Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 131: 1190-1203.
24. Roberts PJ, Der CJ (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26: 3291-3310.
25. Rush J, Moritz A, Lee KA, Guo A, Goss VL, et al. (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat Biotechnol 23: 94-101.
26. Sundaram MV (2006) RTK/Ras/MAPK signaling. WormBook 1-19.
27. Thingholm TE, Jorgensen TJ, Jensen ON, Larsen MR (2006) Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nat Protoc 1: 1929-1935.
28. Varon C, Mosnier JF, Lehours P, Matysiak-Budnik T, Megraud F (2009) Gastric carcinogenesis and Helicobacter pylori infection. Methods Mol Biol 511: 237-265
29. Wilson-Grady JT, Villen J, Gygi SP (2008) Phosphoproteome analysis of fission yeast. J Proteome Res 7: 1088-1097.
30. Wu J, Shakey Q, Liu W, Schuller A, Follettie MT (2007) Global profiling of phosphopeptides by titania affinity enrichment. J Proteome Res 6: 4684-4689.
31. Wu WK, Sung JJ, Yu L, Li ZJ, Chu KM, et al. (2008) Constitutive hypophosphorylation of extracellular signal-regulated kinases-1/2 and down-regulation of c-Jun in human gastric adenocarcinoma. Biochem Biophys Res Commun 373: 330-334
32. Yan F, Cao H, Chaturvedi R, Krishna U, Hobbs SS, et al. (2009) Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. Gastroenterology 136: 1297-1307.
33. Yan G, Li L, Tao Y, Liu S, Liu Y, et al. (2006) Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology. Proteomics 6: 1810-1821.